Search

Search Constraints

You searched for: Author/Creator Markulev, Connie

Search Results

1. Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention Trial. Issue 1 (2nd March 2020)

2. Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial. Issue 5 (8th September 2022)

3. Enhanced cortisol suppression following administration of low-dose dexamethasone in first-episode psychosis patients. (April 2013)

4. Greater preference for eveningness is associated with negative symptoms in an ultra‐high risk for psychosis sample. Issue 6 (3rd February 2021)

6. NEURAPRO‐E study protocol: a multicentre randomized controlled trial of omega‐3 fatty acids and cognitive‐behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Issue 5 (16th August 2015)

7. O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL. (1st April 2018)

8. Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis. Issue 4 (6th September 2020)

9. Prediction of clinical outcomes beyond psychosis in the ultra‐high risk for psychosis population. Issue 3 (17th June 2020)

10. S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING. (1st April 2018)